ArticleMaterials (Basel, Switzerland)2025
Nanocomposite Polysulfone/CB Modified by Melt Extrusion and Solution Mixing for Enhanced Removal of Uremic Toxins.
Article in Materials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, polysulfone-based nanocomposites with carbon black (CB) nanoparticles were fabricated to evaluate their urea-removal properties. The nanocomposites were obtained using two different methods: solution mixing and melt extrusion. These materials were evaluated using Fourier transform infrared spectroscopy (FTIR), which allowed for the identification of the corresponding functional groups within the polysulfone polymer matrix. X-ray diffraction (XRD) analysis was performed, confirming the amorphous structure of the polysulfone. The addition of modified carbon black shifted the most intense peak of the polysulfone. Thermogravimetric analysis (TGA) showed an increase in thermal stability with the addition of different concentrations of modified carbon black for solution-mixing method. Scanning electron microscopy (SEM) revealed that the melt-extrusion method presented a better dispersion of the nanoparticles, since large agglomerates were not observed. Additionally, a urea adsorption study was conducted, obtaining removal percentages of 76% and 72% for the extrusion and solution-mixing methods, respectively. It was demonstrated that the nanocomposite can be used for up to five cycles without losing urea-removal efficiency, whereas the efficiency of pure polysulfone decreases as the number of cycles increases. Finally, the hemolysis test was performed, and the nanocomposites showed less than 1% hemolysis, indicating that the material is non-hemolytic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.